Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study record for poziotinib in advanced EGFR exon 20-mutant NSCLC is displayed, with details on eligibility, study design, outcomes, dates, and related documents.
    Difference
    50%
    Check dated 2026-11-07T12:35:55.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:21:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence.” The clinical study record remains unavailable on the page.
    Difference
    1%
    Check dated 2026-10-24T13:06:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:07:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:03:59.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in the page body, with a Home link, rather than clinical study details.
    Difference
    0.5%
    Check dated 2026-10-03T14:04:49.000Z thumbnail image

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.